Utilization of Pharmacy Claims Data to Evaluate Therapeutic Interchange . Programs
نویسندگان
چکیده
SCOTT BULL, PHARM.D., is a Pharmacy Research Analyst, Kaiser Permanente Division of Research, Oakland, CA At the time of the study, he was Pharmacoeconomics/Outcomcs Research Fellow, Novartis Pharmaceuticals/Kaiser Permanente. OMAR SHOHEIBER, PHARMD., is Vice PresidcntPmduct Development, Tricore Technologies, North Brunswick, NJ At the time of the study, he was Associate Director, Outcomes Research and Informatics, Novar.tis Pharmaceuticals, East Hanovel; NJ MICHAEL BAILEY, RPH., is Director of Advanced Pmgmms, Medimpact, San Diego, CA At the time of the study, he was Director of Pharmacy, Health Plan of the Redwoods, Santa Rosa, CA DIANA BRlXNER, PH.D., RPH., is Vice President, Health Care Management, Novartis Pharmaceuticals, East Hanovel; N]
منابع مشابه
Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
BACKGROUND Outpatient drugs are dispensed through both community and mail order pharmacies. There is no empirical evidence that substitution of community pharmacy with mail order reduces overall drug expenditures. The need for evaluating the potential effects on utilization and costs of the possible extension of mail order services in Medicaid provides the rationale for conducting this study. T...
متن کاملCommunity pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
BACKGROUND Pharmacy benefit management (PBM) companies promote mail order programs that typically dispense 90-day quantities of maintenance medications, marketing this feature as a key cost containment strategy to address plan sponsors' rising prescription drug expenditures. In recent years, community pharmacies have introduced 90-day programs that provide similar cost advantages, while allowin...
متن کاملGuidelines for therapeutic interchange-2004.
This publication is an update of the American College of Clinical Pharmacy (ACCP) Position Statement on “Guidelines for Therapeutic Interchange,” originally published in 1993. The ACCP supports the practice of therapeutic interchange, in which pharmacists collaborate with physicians and other health care professionals to develop policies and implement programs that improve drug use to provide t...
متن کاملTherapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidence of hospital-acquired VTE may increase the prescribing of thromboprophylactic agents recommended in VTE management guidelines. As a result, more p...
متن کاملACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008.
BACKGROUND Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are widely prescribed for the treatment of hypertension and heart failure, as well as for kidney disease prevention in patients with diabetes mellitus and the management of patients after myocardial infarction. OBJECTIVE To (a) describe ACE inhibitor and ARB utilization and spending in the Medic...
متن کامل